Immunotherapy for Lung Cancer: Are Combination Regimens a Path Forward? – Cancer Therapy Advisor
Cancer Therapy Advisor |
Immunotherapy for Lung Cancer: Are Combination Regimens a Path Forward?
Cancer Therapy Advisor The results have been “eagerly awaited because both IL-15 and PD-1 or PD-L1 blockers are ranked in the top three classes of immunotherapy drugs that could potentially cure cancer,” Dr Rolfo and Dr Smits wrote. “IL-15 triggers the activation of both … |
